Viralgen developed a dedicated platform and a designed-for-use cell line, which combine to improve efficiency and reduce costs
Consistency in gene therapy manufacturing is essential for delivering safe, effective treatments to patients. However, maintaining uniformity in production processes poses significant challenges, from raw material variability to complex biological systems. This article explores how the biotech industry is adopting new technologies and strategies to enhance consistency across the gene therapy manufacturing lifecycle, ensuring that therapies meet rigorous quality standards from development to commercialization.
